The critique discusses fifty eight peptides in numerous clinical phases, indicating a strong pipeline of peptide therapies focusing on PPIs. Clinical trials and preclinical studies are highlighted, showing the efficacy of peptide vaccines in inducing an immune response, with the prospective to boost survival fees for HCC individuals. Peptides